Today: 28 November 2025
Subscribe
Browse Tag

Mergers

Lord Rothermere’s £500m Telegraph Takeover: How the Daily Mail Deal Is Reshaping UK Media on 26 November 2025

Lord Rothermere’s £500m Telegraph Takeover: How the Daily Mail Deal Is Reshaping UK Media on 26 November 2025

Published: 26 November 2025 While British politics grapples with new allegations about Nigel Farage’s schooldays racism, another story is capturing people’s imagination: a celebration of the country’s quiet, everyday heroes – from a bus driver in West Yorkshire to a
26 November 2025
 ·  ·  ·  · 
Enviri (NVRI) Soars as It Sells Clean Earth to Veolia for $3.04 Billion and Unveils “New Enviri” Spin‑Off

Enviri (NVRI) Soars as It Sells Clean Earth to Veolia for $3.04 Billion and Unveils “New Enviri” Spin‑Off

Enviri Corporation (NYSE: NVRI) has kicked off one of the most consequential restructurings in its 170‑year history, agreeing to sell its Clean Earth hazardous‑waste business to France’s Veolia Environnement for $3.04 billion in cash and unveiling plans to spin off
21 November 2025
 ·  ·  ·  ·  · 
Euronext Paris Shocks Markets with Historic Roots, Surging Stocks & Bold 2025 Moves

Euronext Today, 18 November 2025: European Stocks Slide as Eutelsat’s €828m Capital Raise, Nexans Buyback and AkzoNobel–Axalta Mega‑Merger Dominate Trade

European equities on Euronext are under pressure today, 18 November 2025, as investors digest a fresh wave of capital‑raising, buybacks and a blockbuster cross‑border merger against a backdrop of global risk‑off sentiment. By late morning in Europe, the Euronext 100
18 November 2025
 ·  ·  ·  · 
CMCT Sells Lending Arm to Peachtree Affiliate for ~$44M; Stock Jumps, CFO Transition Set — Nov. 12, 2025

CMCT Sells Lending Arm to Peachtree Affiliate for ~$44M; Stock Jumps, CFO Transition Set — Nov. 12, 2025

Creative Media & Community Trust Corporation (NASDAQ: CMCT) said it has signed a definitive agreement to sell its lending division to PG FR Holding, LLC, an affiliate of Atlanta-based Peachtree Group. The deal is expected to generate approximately $31 million
12 November 2025
 ·  ·  ·  ·  · 
Paramount Skydance (NASDAQ: PSKY) Jumps on First Post‑Merger Earnings: $1.5B Content Push, $3B Cost Cuts, Paramount+ Price Hike — 11/11/2025

Paramount Skydance (NASDAQ: PSKY) Jumps on First Post‑Merger Earnings: $1.5B Content Push, $3B Cost Cuts, Paramount+ Price Hike — 11/11/2025

Paramount Skydance Corporation reported its first results since the Skydance–Paramount merger and the stock rallied after management laid out a bigger streaming-and-studios investment plan and raised its cost‑savings target. Shares were up ~5.5% today as CEO David Ellison emphasized a
11 November 2025
 ·  ·  ·  ·  · 
Movano (NASDAQ: MOVE) Soars on All‑Stock Merger With Corvex to Create Secure AI‑Infrastructure Pure Play — Nov. 10, 2025

Movano (NASDAQ: MOVE) Soars on All‑Stock Merger With Corvex to Create Secure AI‑Infrastructure Pure Play — Nov. 10, 2025

What Happened Movano Inc. (NASDAQ: MOVE) and Corvex, Inc., a GPU‑accelerated AI cloud company, signed a definitive all‑stock merger agreement. The combined business will focus squarely on secure, high‑performance AI infrastructure—including GPU clusters for training/inference, confidential computing, and inference‑as‑a‑service—repositioning Movano
10 November 2025
 ·  ·  ·  ·  · 
Pfizer Stock 2025: 7% Dividend, Obesity Gamble, and Wall Street’s Verdict

Novo Nordisk and Pfizer Stocks Today (Nov. 10, 2025): Pfizer Clinches $10B Metsera Deal as Novo Rises on Exit and India Brand Move

Published: November 10, 2025 Summary: On Monday, Pfizer said it will acquire obesity‑drug developer Metsera in a deal worth up to $10 billion, while Novo Nordisk shares climbed after bowing out of the bidding war. Governance drama around Novo’s board
10 November 2025
 ·  ·  ·  ·  ·  · 
Pfizer Stock Surges on Trump Deal & Obesity Drug Drama – Is a Comeback Coming?

Pfizer (PFE) Stock Today — Nov 7, 2025: Metsera Bidding War Intensifies, Dividend Record Date, and What’s Moving the Share Price

Last updated: Nov 7, 2025 (19:23 UTC) Pfizer (NYSE: PFE) shares were trading around $24.28, down roughly 2.3% intraday, as investors weighed new twists in the Metsera takeover fight and marked today’s dividend record date. As of the latest print,
7 November 2025
 ·  ·  ·  ·  ·  · 
1 2 3
Go toTop